Before coming to the LSE, Elena was the coordinator of a clinical trial unit at the University Hospital (CHUV) in Lausanne, Switzerland, conducting mainly research to develop an HIV vaccine. She also participated, as its administrator, in the launch of the Swiss Vaccine Research Institute, one of the first national research platforms in vaccinology encompassing multi-disciplinary fields. In 2009, she did her masters (MSc in Health Policy, Planning, and Financing) at the LSHTM and LSE, and in parallel worked for Prof. Panos Kanavos as a research assistant, and since October 2010 is working full time as a research officer. Her main areas of interest are in pharmaceutical policy, namely in pricing, reimbursement and market access.
Nicod E, Kanavos P. 2012. "Commonalities and differences in HTA outcomes: A comparative analysis of five countries and implications for coverage decisions". Health policy (Amsterdam) (0168-8510) (accepted for publication September 2012, online)
Kanavos P, Nicod E. 2012. "What Is Wrong with Orphan Drug Policies? Suggestions for Ways Forward". Value in health (1098-3015) (accepted for publication September 2012, online)
Elena Nicod, 2010. "Harmonizing the outcomes of HTA: An application to Central Nervous System treatments". EuroObserver. Winter 2010. Volume 12, Number 4.
Panos Kanavos, Elena Nicod, Stacey Van den Aardweg, Stephen Pomedli, 2010. "The impact of health technology assessments: An international comparison". EuroObserver. Winter 2010. Volume 12, Number 4.
Panos Kanavos, Sotiris Vandoros, Rachel Irwin, Elena Nicod, Margaret Casson. 2010. "The European Pharmaceutical market and policies - Outlook for the future". European Parliament. Directorate General for Internal Policies. Policy Department A: economic and scientific Policy.